Corinna C Zygourakis1, Victoria Valencia2, Christy Boscardin3, Rahul U Nayak4, Christopher Moriates2, Ralph Gonzales5, Philip Theodosopoulos6, Michael T Lawton6. 1. Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA; Center for Healthcare Value, University of California, San Francisco, San Francisco, California, USA. Electronic address: corinna.zygourakis@ucsf.edu. 2. Center for Healthcare Value, University of California, San Francisco, San Francisco, California, USA; Department of Medicine, University of California, San Francisco, San Francisco, California, USA; Department of Medicine, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA. 3. Department of Medicine, University of California, San Francisco, San Francisco, California, USA. 4. Center for Healthcare Value, University of California, San Francisco, San Francisco, California, USA. 5. Center for Healthcare Value, University of California, San Francisco, San Francisco, California, USA; Department of Medicine, University of California, San Francisco, San Francisco, California, USA; Continuous Process Improvement Department, UCSF Health, San Francisco, California, USA. 6. Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Abstract
BACKGROUND: There is high variability in neurosurgical costs, and surgical supplies constitute a significant portion of cost. Anecdotally, surgeons use different supplies for various reasons, but there is little understanding of how supply choices affect outcomes. Our goal is to evaluate the effect of patient, procedural, and provider factors on supply cost and to determine if supply cost is associated with patient outcomes. METHODS: We obtained patient information (age, gender, payor, case mix index [CMI], body mass index, admission source), procedural data (procedure type, length, date), provider information (name, case volume), and total surgical supply cost for all inpatient neurosurgical procedures from 2013 to 2014 at our institution (n = 4904). We created mixed-effect models to examine the effect of each factor on surgical supply cost, 30-day readmission, and 30-day mortality. RESULTS: There was significant variation in surgical supply cost between and within procedure types. Older age, female gender, higher CMI, routine/elective admission, longer procedure, and larger surgeon volume were associated with higher surgical supply costs (P < 0.05). Routine/elective admission and higher surgeon volume were associated with lower readmission rates (odds ratio, 0.707, 0.998; P < 0.01). Only patient factors of older age, male gender, private insurance, higher CMI, and emergency admission were associated with higher mortality (odds ratio, 1.029, 1.700, 1.692, 1.080, 2.809). There was no association between surgical supply cost and readmission or mortality (P = 0.307, 0.548). CONCLUSIONS: A combination of patient, procedural, and provider factors underlie the significant variation in neurosurgical supply costs at our institution. Surgical supply costs are not correlated with 30-day readmission or mortality. Copyright Â
BACKGROUND: There is high variability in neurosurgical costs, and surgical supplies constitute a significant portion of cost. Anecdotally, surgeons use different supplies for various reasons, but there is little understanding of how supply choices affect outcomes. Our goal is to evaluate the effect of patient, procedural, and provider factors on supply cost and to determine if supply cost is associated with patient outcomes. METHODS: We obtained patient information (age, gender, payor, case mix index [CMI], body mass index, admission source), procedural data (procedure type, length, date), provider information (name, case volume), and total surgical supply cost for all inpatient neurosurgical procedures from 2013 to 2014 at our institution (n = 4904). We created mixed-effect models to examine the effect of each factor on surgical supply cost, 30-day readmission, and 30-day mortality. RESULTS: There was significant variation in surgical supply cost between and within procedure types. Older age, female gender, higher CMI, routine/elective admission, longer procedure, and larger surgeon volume were associated with higher surgical supply costs (P < 0.05). Routine/elective admission and higher surgeon volume were associated with lower readmission rates (odds ratio, 0.707, 0.998; P < 0.01). Only patient factors of older age, male gender, private insurance, higher CMI, and emergency admission were associated with higher mortality (odds ratio, 1.029, 1.700, 1.692, 1.080, 2.809). There was no association between surgical supply cost and readmission or mortality (P = 0.307, 0.548). CONCLUSIONS: A combination of patient, procedural, and provider factors underlie the significant variation in neurosurgical supply costs at our institution. Surgical supply costs are not correlated with 30-day readmission or mortality. Copyright Â
Authors: Beiqun Zhao; Griffin A Tyree; Timothy C Lin; Florin Vaida; Blake J Stock; Thomas A Hamelin; Bryan M Clary Journal: J Surg Res Date: 2018-12-13 Impact factor: 2.192
Authors: Jamie R Robinson; Nicholas H Carter; Corinne Gibson; Adam S Brinkman; Kyle Van Arendonk; Karen E Speck; Melissa E Danko; Gretchen P Jackson; Harold N Lovvorn; Martin L Blakely Journal: J Pediatr Surg Date: 2018-03-08 Impact factor: 2.545
Authors: Christopher P Childers; Susan L Ettner; Ron D Hays; Gerald Kominski; Melinda Maggard-Gibbons; Rodrigo F Alban Journal: Ann Surg Date: 2021-07-01 Impact factor: 13.787